Viewing Study NCT06397937



Ignite Creation Date: 2024-05-06 @ 8:28 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06397937
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-03
First Post: 2024-04-30

Brief Title: SDOH-Homecare Intervention Focus Team SHIFT Trial to Improve Stroke Outcomes
Sponsor: Columbia University
Organization: Columbia University

Study Overview

Official Title: The SDOH-Homecare Intervention Focus Team SHIFT Trial to Mitigate Structural Racism in Stroke Outcomes and Build Community Capacity The SHIFT Trial
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SHIFT
Brief Summary: Primary Goal

To test the hypothesis that among AA and Hispanic stroke patients 18-75 years with 3 SDOH risk factors SHIFT will improve 1 functional outcomes as measured by the SIS Primary Outcome 2 physiological outcomes as measured by changes in blood pressure and cognition secondary outcomes and 3 epigenetic allostatic load biomarkers exploratory outcome such as DNA methylation DNAm and telomere length at 6 months and 1-year post-stroke compared with usual care UC
Detailed Description: Structural Racism and Discrimination SRD produces adverse Social Determinants of Health SDOH which have been shown increase stroke risk in a dose dependent manner The SDOH-Homecare Intervention Focus Team SHIFT trial is a Phase 3 randomized blinded outcome trial that tests the hypothesis that a homecare intervention shortly after discharge from an acute stroke unit by a team comprising a community health worker CHW a community social worker CSW and a community nurse CN can improve health outcomes among Black and Hispanic stroke patients compared with UC

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None